Keson-Brookes Maiken 4
4 · Mural Oncology plc · Filed Jul 18, 2024
Insider Transaction Report
Form 4
Keson-Brookes Maiken
See Remarks
Transactions
- Sale
Ordinary Shares
2024-07-18$3.41/sh−2,157$7,355→ 43,850 total
Footnotes (2)
- [F1]Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 14, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement that includes a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on December 22, 2023, and the sale does not represent a discretionary trade by the Reporting Person.
- [F2]Includes 38,705 unvested restricted stock units.